Research Review: Omega-3 supplementation to reduce antisocial behavior - a systematic review and meta-analysis of randomized controlled trials
Abstract
Background: Omega-3, a long-chain fatty acid critical for brain structure and function, has been argued to be effective in reducing antisocial behavior, but findings are variable. This meta-analysis examines 25 randomized controlled trials (RCTs) with a total of 2,889 participants.
Methods: This study was registered with PROSPERO (CRD42021256959). Two separate analyses were conducted where the unit of analysis was independent studies and independent laboratories.
Results: Significant effect sizes (p < .001) were observed for both analyses (g = .13, .14 respectively) and in the direction of omega-3 supplementation reducing antisocial behavior. There was equivocal evidence of publication bias. Study quality was good. Stratified analyses were nonsignificant for age, gender, dose, sample size, and study quality, although the effect size was larger for unmedicated participants. Combining these data with a recent meta-analysis on aggressive behavior produced an overall effect size of g = .22 for externalizing behavior based on 36 nonoverlapping RCTs.
Conclusions: Given that omega-3 supplementation is relatively cheap, easy to implement, transfers well from the research environment to community settings, and has additional health benefits, it is suggested that it may be considered as an adjunctive intervention for the treatment of antisocial and externalizing behavior.
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 2,889 participants or records.
Read the paper
Related studies
- Promising Sources of Plant-Derived Polyunsaturated Fatty Acids: A Narrative Review
- Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: Systematic review and meta-analysis of randomized controlled trials
- Effect of omega-3 fatty acids on cognition: an updated systematic review of randomized clinical trials
- The role of omega-3 polyunsaturated fatty acid supplementation in the management of type 2 diabetes mellitus: A narrative review
- Paucity of evidence for a relationship between long-chain omega-3 fatty acid intake and chronic obstructive pulmonary disease: a systematic review
- Omega-3 fatty acid nanocarriers: Characterization and potential applications
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.